Evaluating First-line Chemotherapy Regimens and Platinum Choices in HER2-Negative Metastatic Gastric Cancer: A Retrospective Analysis

Objective: The survival advantage of triplet versus doublet chemotherapy regimens and cisplatin versus oxaliplatin-based therapies for first-line treatment in human epidermal growth factor receptor 2 (HER2)-negative metastatic gastric cancer remains unclear. This study aimed to evaluate and compare...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Caner ACAR, Haydar Çağatay YÜKSEL, Salih TÜNBEKİCİ, Gökhan ŞAHİN, Fatma Pınar AÇAR, Burçak KARACA
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Turkish Society of Oncology 2025-08-01
Sarja:	Journal of Oncological Sciences
Aiheet:	adenocarcinoma cancer diagnosis and treatments medical oncology
Linkit:	https://journalofoncology.org/articles/evaluating-first-line-chemotherapy-regimens-and-platinum-choices-in-her2-negative-metastatic-gastric-cancer-a-retrospective-analysis/doi/jos.galenos.2025.2025-6-2
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!